Investor's Watch List FirstEnergy Corp. (NYSE:FE), Horizon Pharma PLC (NASDAQ:HZNP)


Morgan Stanley now owns 1,408,682 shares of the biopharmaceutical company's stock valued at $25,539,000 after buying an additional 703,768 shares in the last quarter. The company has market cap of $1.66 billion. The stock decreased 0.06% or $0.02 on May 26, reaching $34.02. Indicating how profitable this stock is relative to its assets, the ROA value is observed at -3.90%. Norwood Financial Corporation (NASDAQ:NWFL) has risen 39.29% since May 30, 2016 and is uptrending. It has outperformed by 7.28% the S&P500. Citigroup upgraded Horizon Pharma PLC (NASDAQ:HZNP) on Monday, November 28 to "Buy" rating. First Mercantile Trust Co. now owns 11,770 shares of the biopharmaceutical company's stock valued at $174,000 after buying an additional 310 shares in the last quarter. Morgan Stanley increased its stake in shares of Horizon Pharma PLC by 99.8% in the third quarter. Insiders own 33.00% of the company shares.

The stock of Horizon Pharma PLC (NASDAQ:HZNP) is a huge mover today! It has underperformed by 44.83% the S&P500.

Since February 28, 2017, it had 1 insider purchase, and 1 sale for $414,996 activity.

In related news, EVP Robert Carey sold 31,808 shares of the business's stock in a transaction that occurred on Wednesday, March 1st. The most optimistic analyst sees the stock reaching $22 while the most conventional has $10 target price if we look at the price target with an optimistic approach it has upside potential of 116% from its recent closing price of $10.20. Point72 Asset L P holds 0.06% in Horizon Pharma PLC (NASDAQ:HZNP) or 572,900 shares. Therefore 56% are positive. Finally, Guggenheim assumed coverage on shares of Horizon Pharma PLC in a research report on Monday, February 27th. The company presently has a consensus rating of "Buy" and a consensus target price of $21.38. Beach Point Capital Management LP now owns 522,898 shares of the biopharmaceutical company's stock worth $7,728,000 after buying an additional 309,354 shares during the last quarter. Mizuho cut Horizon Pharma PLC from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $22.00 to $10.00 in a report on Tuesday, May 9th.

Receive News & Ratings for Horizon Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Pharma PLC and related companies with's FREE daily email newsletter. The stock of Horizon Pharma PLC (NASDAQ:HZNP) earned "Market Perform" rating by Cowen & Co on Friday, September 16. EPS growth percentage represents the annualized rate of net-income-per-share growth over the trailing one-year period for the stocks held by a stock. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company.

Horizon Pharma Plc Ord Ireland (NASDAQ:HZNP) had an increase of 10.05% in short interest. About 400 shares traded. Texas Permanent School Fund owns 0% invested in Crocs, Inc. Chipotle Mexican Grill Inc (NYSE:CMG) was reduced too.

More news: Rajasthan HC wants cow to be declared national animal
More news: Judge rebukes Trump over travel ban
More news: Cypress Capital Management LLC Buys Shares of 2500 Texas Instruments Incorporated (TXN)

Investors sentiment decreased to 1.02 in Q4 2016. Narrowing in a bit closer, the 5 month price index is 0.60750, the 3 month is 0.61893, and the 1 month is now 0.65849.

Horizon Pharma Public Limited Company (NASDAQ:HZNP)'s latest quote $10.2 $1.15 2.31% will find technical support in $10.02 a share and a breakdown below this region would be a significantly bearish signal for Horizon Pharma Public Limited Company traders. Capital Fund Management S.A. boosted its position in Horizon Pharma PLC by 142.9% in the third quarter. The biopharmaceutical company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.25 by $0.04. Ins Communications Tx, Texas-based fund reported 152,550 shares. Nuveen Asset Mngmt Limited Liability invested in 0% or 27,898 shares. Tudor Investment Et Al holds 50,598 shares.

Horizon Pharma Public Limited Company (NASDAQ:HZNP) shares have moved -2.86% on the week. Invesco Limited holds 0% or 60,601 shares in its portfolio. As per Tuesday, December 13, the company rating was downgraded by Deutsche Bank. Credit Suisse Ag has 224,618 shares. Numeric Invsts Ltd Liability Corp has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP).

Horizon Pharma PLC (NASDAQ:HZNP) last released its quarterly earnings results on Monday, May 8th.

Alps Advsr holds 154,966 shares or 0.02% of its portfolio. Great Lakes Llc accumulated 30,042 shares.

Horizon Pharma Public Limited Company (NasdaqGS:HZNP) has a current MF Rank of 11108. Swiss Bancorporation holds 0.01% or 235,356 shares. Manufacturers Life Insur The holds 0% or 109,632 shares. Its up 0.28, from 1.16 in 2016Q3. It is negative, as 76 investors sold KO shares while 623 reduced holdings. An investor looking to avoid high risk investments would contain avoided speculative stocks during dot-com bubble based on beta measurements. (NYSE:GAM). Overbrook holds 1.42% of its portfolio in General American Investors Co. Inc.